Clinical effects of Apatinib combined with DOS neoadjuvant chemotherapy regimen in neoadjuvant chemotherapy for LAGC

OBJECTIVE: To evaluate the clinical effects of apatinib combined with DOS regimen in the neoadjuvant chemotherapy for locally advanced gastric cancer (LAGC). METHODS: Eighty patients with LAGC admitted to Baoding first Central Hospital from January 2018 to October 2020 were randomly divided into two...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Peng-zhe, Gao, Lei, Wu, Wei, Hao, Ying-xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publications 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613054/
https://www.ncbi.nlm.nih.gov/pubmed/34912413
http://dx.doi.org/10.12669/pjms.37.7.4265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613054/
https://www.ncbi.nlm.nih.gov/pubmed/34912413
http://dx.doi.org/10.12669/pjms.37.7.4265

Ejemplares similares